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Summary 
During acute inflammation, P-selectin is transiently mobilized from Weibel-Palade bodies to 
the surface of histamine-activated endothelial cells, where it mediates rolling adhesion of neu- 
trophils under hydrodynamic flow. During chronic or allergic inflammation, sustained expres- 
sion of P-selectin on the endothelial cell surface has been observed. We found that the cytokines 
interleukin 4  (IL-4) or oncostatin M  (OSM) induced a five- to ninefold increase in P-selectin 
messenger RNA (mlLNA) in human umbilical vein endothelial cells  (HUVEC) that persisted 
as long as 72 h. IL-4 elevated P-selectin mRNA by increasing its transcription rate rather than 
by prolonging its already long half-life. Stimulation of P-selectin transcription by IL-4 or OSM 
required  new protein synthesis and tyrosine phosphorylation of cellular proteins.  Tumor ne- 
crosis factor 0r  IL-113, lipopolysaccharide, or IL-3 did not increase P-selectin mlLNA in HU- 
VEC, and did not augment the IL-4-induced increase in P-selectin transcripts.  IL-4 or OSM 
increased P-selectin protein on the cell surface as well as in Weibel-Palade bodies. Under flow 
conditions,  neutrophils  rolled  on  P-selectin  expressed  by  IL-4-treated  H UVEC,  and  even 
more neutrophils rolled on P-selectin after IL-4-treated HUVEC were stimulated with hista- 
mine. These data demonstrate that IL-4 or OSM stimulates endothelial cells to synthesize more 
P-selectin  over prolonged  periods.  The increased  expression  of P-selectin may facilitate the 
emigration of leukocytes into sites of chronic or allergic inflammation. 
L 
eukocyte emigration into lymphoid tissues  and sites  of 
inflammation is mediated by the sequential engagement 
of adhesion  molecules.  Molecules  that  transmit  signals  to 
leukocytes,  endothelial  cells,  or platelets  regulate  the  ex- 
pression and/or function  of the  adhesion molecules.  Spe- 
cific combinations of signaling and adhesion molecules may 
control the onset and duration of leukocyte recruitment, as 
well as the subclasses  of leukocytes that are mobilized, dur- 
ing acute, chronic, or allergic inflammation (1). 
The  binding  of  selectins  to  cell-surface  carbohydrate 
ligands mediates the initial  tethering and rolling of leuko- 
cytes on the vessel wall under conditions of hydrodynamic 
flow (2).  Subsequent leukocyte activation promotes stable 
adhesion through engagement of [32 integrins with Ig-like 
counterreceptors  such  as  intercellular  adhesion  molecule 
(ICAM)-I 1 and ICAM-2  (1).  Depending  on their activa- 
I  Abbreviations used in this paper: HUVEC, human umbilical vein endothe- 
lial cells; ICAM-1, intracellular adhesion molecule-I; OSM, oncostatin 
M; STAT, signal transducer and activator  of transcription; VCAM-1, vas- 
cular cell adhesion molecule-I. 
tion state,  the or4 integrins on mononuclear cells,  eosino- 
phils, and basophils mediate both tethering and stable adhe- 
sion  through  interactions  with  the  Ig  counterreceptors, 
vascular cell  adhesion  molecule  (VCAM)-I,  and  mucosal 
addressin cell adhesion molecule-1 (3, 4). 
TNF-ci, IL-I[3, and LPS participate in acute inflamma- 
tion, where neutrophils preferentially accumulate, but they 
may also be present at sites of chronic inflammation. These 
mediators stimulate endothelial cells  to transcribe mRNAs 
encoding E-selectin, ICAM-1, and VCAM-1  (5).  In vivo, 
the selective expression of VCAM-1  is associated with the 
accumulation  of mononuclear  leukocytes  or  eosinophils 
during chronic or allergic inflammation (6-13). IL-4, a cy- 
tokine expressed by CD4 + T  cells, basophils, and mast cells 
(14-17), is frequently detected at the same sites (18,  19).  In 
vitro, IL-4 induces human umbilical vein endothelial  cells 
(HUVEC)  to  synthesize  VCAM-1,  but  not E-selectin  or 
ICAM-1. VCAM-1 mediates adhesion ofmononuclear cells, 
eosinophils, and basophils, but not neutrophils,  to the en- 
dothelial  cell  surface  (20-22).  Under  shear  stress,  mono- 
cytes attach  and  roll on IL-4-activated HUVEC  through 
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(23).  These  data suggest that IL-4 promotes emigration of 
mononuclear cells or eosinophils during chronic and aller- 
gic inflammation, in part, by inducing the selective expres- 
sion of VCAM-1  on  the  endothelium.  Another potential 
mediator of chronic inflammation is oncostatin M  (OSM), 
which is secreted by monocytes and activated T  cells (24). 
OSM  stimulates  release  of plasminogen  activator  activity 
from bovine endothelial cells (25) and expression oflL-6 in 
HUVEC  (26). It is not known whether OSM alters the ex- 
pression of adhesion molecules on endothelial cells. 
P-selectin is stored in the membranes  of the a  granules 
of platelets (27,  28)  and  the Weibel-Palade bodies of en- 
dothelial cells (29,  30).  Upon  stimulation of these cells by 
agonists such as thrombin, histamine, and complement com- 
ponents,  P-selectin  is  rapidly  mobilized  to  the  plasma 
membrane, where it mediates the adhesion of neutrophils, 
monocytes,  eosinophils, basophils, and subsets of lympho- 
cytes (31-36).  The protein is then rapidly internalized (37, 
38)  and  targeted to lysosomes for  degradation  (39)  or,  in 
some cases, resorted into secretory granules (40). This rapid 
but self-limited surface expression enables P-selectin to me- 
diate leukocyte tethering to the vessel wall during the earli- 
est stages of acute inflammation (41, 42). 
Persistent expression of P-selectin on the endothelial cell 
surfa.ce  has also been observed in tissues with chronic or al- 
lergic inflammation such as rheumatoid synovium (43), ath- 
erosclerotic  plaque  (44),  and  nasal  polyp  (45).  In  vitro, 
TNF-a  or LPS induces a  two- to fourfold increase in the 
steady-state levels  of P-selectin  transcripts in  murine  and 
bovine endothelial cells (46-48). This increased synthesis of 
P-selectin may saturate the sorting pathway into secretory 
granules, leading to direct delivery of the protein to the cell 
surface (47). In vivo, TNF-a  or LPS also increases the lev- 
els of P-selectin mRNA  and protein in endothelial cells of 
mice and rats (46, 48-50). Both in vitro and in vivo, how- 
ever,  the  increased mRNA  levels peak  within  2-4  h  and 
decline  to  basal  levels  within  12-24  h  after  addition  of 
TNF-a  or LPS. Thus,  it is not clear whether the effects of 
these mediators are sufficient to  account for the persistent 
and selective expression of P-selectin in certain tissues with 
chronic and allergic inflammation. Furthermore,  unlike its 
effects  in  cultured  rodent  and  bovine  endothelial  cells, 
TNF-0c  does not  increase P-selectin mP,  NA  in  HUVEC 
(51).  These data suggest that mediators other than TNF-a 
and  LPS  might  increase  the  transcription  of  P-selectin 
mRNA  during some inflammatory responses. 
In this study, we demonstrate that  either IL-4 or OSM 
causes a  sustained accumulation  of P-selectin mR.NA and 
protein in cultured HUVEC.  This mechanism to increase 
expression  of P-selectin  may  facilitate  the  emigration  of 
leukocytes into sites of chronic or allergic inflammation. 
Materials and Methods 
Reagents andAntibodies.  The  anti-human  P-selectin  mAbs 
$12 and G1 were characterized as described (32, 52). Human rlL-4, 
murine  IL-4,  human  OSM,  and  human  IL-3  were  purchased 
from R  & D Systems, Inc. (Minneapolis, MN). Recombinant hu- 
man TNF-0c, human IL-113, and Nutridoma SP serum-free me- 
dium were  obtained from Boehringer Mannheim Biochemicals 
(Indianapolis, IN).  LPS from Salmonella typhosa, cycloheximide, 
LPS-free gelatin, polymyxin B,  and  actinomycin D  were  pur- 
chased from Sigma Chemical Co.  (St. Louis, MO).  Herbimycin 
A  and genistein were obtained from Calbiochem-Novabiochem 
Co. (La Jolla, CA). All other reagents were obtained from Fisher 
Scientific (Pittsburgh, PA) unless noted otherwise. 
Cell Culture.  HUVEC were isolated and cultured in medium 
199 containing 20% human serum, 2 mM glutamine, 100 U/ml 
penicillin, and 100 pxg/ml of streptomycin as described (53). Cells 
were grown to confluence on LPS-free, gelatin-coated tissue cul- 
ture  plastic. Passage  1  cells were  used in  all experiments illus- 
trated.  However,  similar responses to  cytokines were  observed 
with cells studied after two or three passages. Cytokines or phar- 
macologic agents, dissolved in fresh medium, were added to the 
confluent cells for the time intervals and at the final concentra- 
tions indicated in the text. As a control, fresh medium lacking the 
cytokine or pharmacologic agent  was  added to  other  cells.  In 
other  experiments,  Nutridoma  SP  serum-free  medium,  in  the 
presence or absence of a cytokine, was added to the cells. As de- 
termined by Northem blot analysis, HUVEC responded similarly 
to cytokines whether they were dissolved in fresh medium  199 
containing human  serum or dissolved in Nutridoma SP serum- 
free medium. 
Human lung microvascular endothelial cells were obtained from 
Clonetics (San Diego, CA) and cultured in medium supplied by 
the manufacturer (modified MCDB medium supplemented with 
5% FBS, 12 ng/ml bovine brain extract, 10 ng/ml human epider- 
mal  growth  factor,  1  ng/ml  hydrocortisone,  50  Ixg/ml genta- 
micin, and 50  ng/rrd amphotericin).  Passage  4  or 5  cells  were 
used in all experiments illustrated. Murine bEnd.3 endothelioma 
cells  (47)  were grown in DMEM  containing  10%  FBS, 2  mM 
glutamine,  100  U/ml penicillin, and  100  Ixg/ml streptomycin. 
Human  rmcrovascular endothelial ceils and  bEnd.3  cells  were 
treated with cytokines as described for HUVEC, except that mu- 
rine IL-4 was used instead of human  IL-4 to treat bEnd.3 cells. 
Cells used in all experiments were determined to be free of my- 
coplasma, as measured by a PCR-based detection system (Strata- 
gene, San Diego, CA). 
Northern Blot Analysis.  Northern  blot analysis  of total P,.NA 
isolated from  confluent  endothelial cells was  performed as  de- 
scribed (54).  The  32p-labeled probes were  a  1.4-kb SmaI frag- 
ment of human P-selectin cDNA (54), a BstXI-linearized plasmid 
containing a human VCAM-I-Ig cDNA chimera (55),  a 2.9-kb 
XbaI fragment of human E-selectin cDNA (56), a BamHI-linear- 
ized plasmid containing the  entire  CHO-B  cDNA  (57),  and  a 
HindIII-linearized CDM8 plasmid containing murine P-selectin 
cDNA (46). Quantification of RNA was performed by densitom- 
etry using a Model GS-670 imaging densitometer (Bio Rad Lab- 
oratories, Hercules, CA). The scans were normalized according 
to the levels of CHO-B transcripts, which did not change when 
endothelial cells were treated with cytokines. 
Nudear Run-on Analysis.  HUVEC  were  incubated  in  fresh 
medium in the presence or absence of 20 ng/ml of IL-4 for 10 h 
at 37~  Cell nuclei were isolated and nuclear run-on assays were 
performed as described (58). Equal amounts of 32p-labeled,  newly 
transcribed R.NA from unstimulated or IL-4-stimulated HUVEC 
were  hybridized with  target  DNAs  that  were  immobilized on 
Hybond-N membranes using a Bio Rad slot-blot apparatus. The 
target  DNAs  were  the  SmaI  fragment  of  human  P-selectin 
cDNA, the linearized plasmid containing the CHO-B cDNA, or, 
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Haven, CT) lacking any cDNA insert. 
Binding of 12sI-$12 to HUVEC.  Binding of 125I-labeled mAb 
$12 to fixed or nonfixed HUVEC monolayers was performed as 
described (37, 59). 
Quantification of P-Selectin by ELISA.  HUVEC in six-well plates 
were lysed with 500  0.1 of 0.1  M  sodium phosphate, pH 8.0,  1% 
Triton X-100, 1.5 ~g/ml aprotinin, 1 mM PMSF, 5 ~g/ml pepsta- 
tin A, 21  ~M leupeptin, and 27 mM iodoacetamide. The lysates 
were centrifuged at 10,000 g for 10 rain. P-selectin antigen in the 
supematants was measured by ELISA, using recombinant soluble 
P-selectin as standard (60). 
Adhesion  of Neutrophils  to HUVEC  under Static or Flow Condi- 
tions.  Adhesion of human neutrophils to HUVEC  under static 
conditions was performed as described (32,  53).  Neutrophil at- 
tachment to HUVEC  under hydrodynamic flow conditions was 
measured in a parallel-plate flow chamber as described (61, 62). 
Results 
Stimulation  of  HUVEC  with  IL-4  Increases mRNA  for 
P-Selectin and  VCAM- 1, but Not for E-Selectin.  To  deter- 
mine  whether  IL-4  affected  the  amount  of  P-selectin 
mRNA  in HUVEC,  we treated confluent cell monolayers 
with 20 ng/ml of human rlL-4 for various intervals. Steady- 
state levels of P-selectin mRNA  were measured by North- 
em  blot  analysis of equivalent  amounts  of RNA  isolated 
from each group of cells. As demonstrated previously (54), 
unstimulated  HUVEC  expressed  mRNA  for  P-selectin 
(Fig. 1 A). IL-4 markedly increased the levels of P-selectin 
mRNA.  Transcripts did not accumulate until 10 h  after the 
addition of IL-4; mRNA  levels reached a  maximum  after 
24 h  and remained at this level for at least 32 h  (Fig. 1 A). 
In other experiments, mRNA  remained at maximal levels 
for up to 72 h  after addition of IL-4 (data not shown).  The 
membrane was rehybridized with a probe encoding CHO-B, 
a  ubiquitously expressed transcript that  does not  change  its 
levels when  cells are stimulated (57).  Quantification of the 
P-selectin transcripts, normalized for the amount of CHO-B 
mRNA,  indicated that IL-4 increased P-selectin mRNA  by 
seven- to ninefold after 24-32 h  (Fig.  1 B).  IL-4 increased 
P-selectin mRNA  in  a  concentration-dependent  manner, 
with near-maximal levels achieved at a concentration of 10 
ng/ml (data not shown). The effect oflL-4 was not caused 
by contamination with LPS,  since boiled IL-4 did not in- 
crease  P-selectin  transcripts.  Indeed,  exogenous  LPS  did 
not alter P-selectin mRNA  (Fig. 1 A). 
Rehybridization  of  the  membrane  with  probes  for 
E-selectin and VCAM-1  indicated that unstimulated HU- 
VEC  did not  express transcripts for either molecule.  IL-4 
induced  the  accumulation  of mRNA  for  VCAM-1,  but 
not  for E-selectin,  confirming previous  observations  (63). 
Transcripts for VCAM-1 increased more rapidly than those 
for P-selectin  (Fig.  1 A). LPS markedly increased mRNA 
for both E-selectin and VCAM-1. 
Stimulation  of HUVEC  with  OSM  Increases mRNA  for 
P-Selectin,  but Not for E-Selectin  or  VCAM-1.  Although 
OSM  is known to  stimulate HUVEC  through interactions 
with a high affinity receptor (26), its ability to affect expres- 
Figure  1.  Stimulation of HUVEC  with  IL-4  increases mKNA for 
P-selectin and VCAM-1 but not for E-selectin. (A) Confluent monolay- 
ers of HUVEC  were  treated with fresh medium  containing 20 ng/ml 
IL-4 or with fresh medium  alone. To ensure that the  observed effects 
oflL-4 were not caused by contaminating LPS, some cells were treated 
with IL-4 that was boiled to inactivate the cytokine, or with 10 ng/ml of 
exogeneously added LPS. After the indicated time, total RNA was iso- 
lated, and 20 ~g of RNA from each group of cells was electrophoresed 
and then transferred to a Hybond-N membrane for Northern blot analy- 
sis. The same membrane was sequentially hybridized with the indicated 
cDNA probes. The mobilities of the hybridized transcripts corresponded 
to published values. (B) The IL-4-induced increase in P-selectin m.KNA 
was quantified  by densitometric  scanning. The level ofP-selectin mRNA in 
each lane was normalized  according to the level ofCHO-B mRNA, which 
was not affected  by IL-4. The data are representative of  three independent 
experiments. 
sion of adhesion molecules on these cells has not been studied. 
We treated HUVEC with 10 ng/ml of OSM for various in- 
tervals and then measured the levels ofmRNA  for P-selectin, 
E-selectin, and VCAM-1 by Northern blot analysis (Fig. 2). 
OSM markedly increased transcripts for P-selectin in a man- 
ner much  like that  observed for  IL-4. Transcripts did not 
accumulate  until  10  h  after  addition  of OSM,  reached  a 
maximum after 24-32 h,  and remained at this level for up 
to  72  h.  Densitometric  analysis  indicated  that  OSM  in- 
creased mRNA  levels for P-selectin by five- to sixfold. OSM 
increased  P-selectin  transcripts in  a  concentration-depen- 
83  Yao et al. Figure  2.  Stimulation  of HUVEC  with OSM  increases mRNA for 
P-selectin and VCAM-1, but not for E-selectin. HUVEC were  treated 
with fresh medium in the presence or absence of 10 ng/ml of OSM, 10 
ng/ml of LPS, or 10 ng/rnl of LPS inactivated with 10 ~g/ml of poly- 
myxin B. After the indicated time, total RNA was isolated and analyzed 
by Northern blotting, as described in Fig. 1. The data are representative 
of three independent experiments. 
dent manner, with near-maximal effects at a  concentration 
of 10 ng/ml (data not shown).  OSM  did not induce accu- 
mulation ofmRNA  for E-selectin. Unlike IL-4, OSM  also 
did not increase the levels ofVCA/VI-1  mRNA  (Fig. 2). 
Costimulation of HUVEC with  IL-4 Plus  TNF-oe,  IL-1~3, 
LPS,  or IL-3 Does  Not  Further Increase mRNA for  P-Selec- 
tin.  Costimulation of HUVEC  with IL-4 plus TNF-oL in- 
creases  VCAM-1  RNA  to  a  much  higher  level than  that 
induced by either individual cytokine (63).  We  stimulated 
HUVEC  with TNF-ci, IL-113, LPS,  or IL-3 for various in- 
tervals.  Other  cells  were  treated  with  IL-4,  alone  or  in 
combination with one of the other agonists. We then mea- 
sured  the  levels  of mRNA  for  P-selectin  and  VCAM-1 
(Fig.  3).  As  reported  previously  (6,  63,  64),  TNF-Ix  in- 
creased VCAM-1 mRNA,  and TNF-ot combined with IL-4 
increased  VCAM-1  mRNA  significantly  more  than  the 
level  produced  by  either  cytokine  alone  (Fig.  3  A).  The 
combination of IL-4 with IL-113 or LPS produced a similar 
synergistic increase in VCAM-1  mRNA  (Fig. 3,  B and C). 
In contrast, TNF-ct, IL-I~, or LPS did not increase P-selec- 
tin mRNA  and had little or no effect  on the  IL-4-induced 
increase  in  P-selectin  transcripts  (Fig.  3,  A-C).  In  fact, 
these agonists sometimes decreased P-selectin mRNA  levels 
after 10-24 h  (Fig. 3, A  and C).  IL-3 had little or no effect 
on VCAM-1  or  P-selectin mRNA  and  did  not  augment 
the increases in these transcripts induced by IL-4 (Fig. 3  D). 
IL-4 Does Not  Detectably Affect  the  Half-life  of P-Selectin 
mRNA,  but  Does Increase the  Transcription  of  P-Selectin 
mRNA.  To determine whether IL-4 increased the steady- 
state levels of P-selectin mRNA  by prolonging its half-life, 
Figure 3.  Costimulation  of HUVEC with IL-4 plus TNF-~x, IL-I~, LPS, or IL-3 does not further increase mRNA for P-selectin. HUVEC were 
treated with (A) TNF-~x (100 U/nil), (B) IL-113 (100 U/ml), (C) LPS (10 ng/ml), or (D) IL-3 (10 ng/ml). Other HUVEC were treated with 2(} ng/ml 
of IL-4, alone, or with the indicated mediator. After the indicated time, total RNA was isolated and analyzed by Northern blotting, as described in Fig. 
1. The data are representative of two (A-C) or three (D) experiments. 
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absence  of IL-4  for  24  h,  and  then blocked  further  tran- 
scription by adding actinomycin D. At intervals up to  12 h, 
the  remaining P-selectin mRNA  was  detected  by North- 
ern blot analysis and quantified by densitometry of the blots 
(Fig. 4).  The half-life of P-selectin transcripts in both con- 
trol  (medium only) and IL-4-treated  cells  exceeded  12  h. 
These  results  indicate  that  P-selectin  mRNA  has  a  long 
half-life in both control and IL-4-treated HUVEC. 
When  IL-4  and  actinomycin  D  were  added  simulta- 
neously  to  HUVEC,  there  was  no  increase  in  P-selectin 
mRNA  (data not shown). To confirm that IL-4 increased the 
transcription ofP-selectin ~A,  we used a nuclear run-on 
assay.  Treatment  of HUVEC  with  IL-4  for  10  h  signifi- 
cantly increased the transcription of mRNA  for P-selectin 
(Fig.  5).  Densitometric  analysis  indicated  that  IL-4  in- 
creased  the  transcription of P-selectin mRNA  by four-  to 
fivefold (data not shown). 
Inhibitors of Tyrosine  Kinases Block  the  IL-4-  and  OSM- 
induced Increases in P-Selectin mRNA.  IL-4 and OSM  bind 
to  a  class  of cytokine  receptors  that  transduce  signals,  in 
part,  through  tyrosine  phosphorylation  of a  group  of ty- 
rosine  kinases  and  transcription  molecules  that  associate 
with the ligand-occupied receptors  (65, 66). We pretreated 
HUVEC  with two tyrosine kinase inhibitors, genistein and 
herbimycin  A,  which  suppress  IL-4-  and  OSM-induced 
tyrosine phosphorylation in HUVEC  (67,  68). Both inhib- 
itors blocked the increase in P-selectin mRNA  induced by 
IL-4 or OSM, and also slightly reduced the level of consti- 
tutively expressed  P-selectin  mRNA  (Fig.  6).  This  result 
Figure 5.  IL-4 increases the tran- 
scription of P-selectin mRNA. Cell 
nuclei were  isolated from HUVEC 
that were pretreated with fresh me- 
dium in the presence or absence of 
20  ng/rnl of IL-4  for  10  h.  Equal 
amounts  of  32p-labeled  nuclear 
RNA from unstimnlated and IL-4- 
stimulated  cells were  hybridized 
with unlabeled P-selectin cD'NA, CHO-B cDNA, and a control plBI20 
plasmid that were  immobilized on a Hybond-N membrane with a slot 
blot apparatus. The data are representative of three independent experi- 
nlents. 
supports  a  role  for  tyrosine  phosphorylation  in  the  cyto- 
kine-induced expression  and perhaps  the  constitutive  ex- 
pression ofP-selectin mRNA. 
The  IL-4-  and  OSM-induced  Accumulation  of P-Selectin 
mRNA in HUVEC Requires Protein Synthesis.  The lag pe- 
riod  required  for  HUVEC  to  accumulate  P-selectin 
mRNA  in response to  IL-4 differs from the early accumu- 
lation of transcripts from immediate early genes, which cy- 
tokines  activate  without  a  requirement  for  new  protein 
synthesis  (5,  65,  66).  To  determine  whether  the  IL-4- 
induced  increase  in  P-selectin  mRNA  required  protein 
synthesis,  we  stimulated  HUVEC  with  IL-4  in  the  pres- 
ence  or  absence  of  cycloheximide.  The  cycloheximide- 
treated cells did not increase P-selectin mRNA  in response 
to  IL-4  (Fig.  7).  In  contrast,  these  cells  expressed  higher 
120 - 
loo~ 
2E 
E 
n- 
,r 
z  h- 
E 
._~ 
O 
? 
D.. 
5O 
0 
￿9  IL-4 
￿9  Medium 
--T--T  r  I  T-- 
2  4  6  8  10  12 
Time (h) 
P-selectin mRNA has a long half-hfe in both control  and  Figure 4. 
IL-4--stimulated HUVEC. HUVEC were pretreated  with fresh medium 
or with fresh medium plus 10 ng/ml of IL-4 for 24 h. Actinomycin D (5 
vtg/rnl) was then added to block further transcription. After the indicated 
time,  total RNA was isolated, and P-selectin mRNA was quantified by 
Northern blotting and densitometry. The mRNA level before addition of 
actinomycin D  (time 0) was assigned a value of 100%, and subsequent 
values  were normalized relative  to this value. The data represent the mean + 
SD of three independent experiments for both control and 1L-4-treated 
cells. 
Figure  6.  Inhibitors  of tyrosine kinases block  the  IL-4- and OSM- 
induced increases in P-selectin mP,,NA. HUVEC were  preincubated  at 
37~  with genistein (100 v,M) for 1 h or with herbimycin A (1 IJ,  M) for 
24 h.  Control cells were  not treated with either  agent.  The cells were 
then incubated for 12 h in the presence or absence of 20 ng/ml IL-4 or 
10 ng/ml OSM. Genistein or herbimycin A were maintained at the same 
concentrations during this 24-h incubation. Total RNA was then isolated 
and analyzed by Northern blotting as in Fig. 1. The data are representa- 
tive of three independent experiments. 
85  Yao et al. Figure  7.  The  IL-4-induced  accumulation  of P-selectin  rn~NA  in 
HUVEC requires protein synthesis.  HUVEC were treated  with fresh me- 
dium containing 20 ng/ml IL-4 in the presence or absence of 10 I.tg/ml 
of cycloheximide. After the indicated  time, total  RNA was isolated  and 
analyzed by Northern blotting, as described in Fig. 1. The data are repre- 
sentative  of three independent experiments. 
E-selectin  mRNA  levels,  presumably because  they  could 
not synthesize new Itd3-a to retain heterodimeric NF-KB 
complexes in  the  cytoplasm (69,  70).  These results dem- 
onstrate  that,  to  fully  activate  the  P-selectin  gene,  IL-4 
must first induce the  synthesis of one or more proteins in 
HUVEC.  OSM also  required protein synthesis to increase 
P-selectin mRNA in HUVEC (data not shown). 
Stimulation of  HUVEC with IL-4 or OSM Increases P-Selec- 
tin Protein.  To  determine  whether  the  IL-4-induced in- 
crease in P-selectin mKNA led to an increase in P-selectin 
protein, we treated HUVEC with or without IL-4 for 24 h 
and then measured the  amount of P-selectin protein with 
three  different assays (Fig.  8).  Using an ELISA, we found 
that IL-4 increased P-selectin in cell lysates by nearly three- 
fold (Fig.  8 A). We next compared the levels of surface and 
total P-selectin  by measuring binding  of ~2SI-labeled $12, 
an mAb to  P-selectin,  to fixed,  nonpermeabilized or per- 
meabilized cells.  IL-4 increased both the  surface and total 
levels of P-selectin, although only a small fraction of the to- 
tal P-selectin was on the surface in both control and treated 
cells  (Fig.  8  B).  We  then  added  ~2~I-$12 to  live  cells  at 
37~  which  allowed cumulative binding  of the  antibody 
to P-selectin molecules cycling between endosomes and the 
plasma  membrane  (37,  38).  IL-4  treatment  increased  the 
amount of P-selectin in these two compartments. In both 
control and  IL-4-treated cells,  stimulation with  histamine 
further elevated P-selectin, consistent with fusion of  Weibel- 
Palade membranes with  the plasma membrane (Fig.  8  C). 
These  data  demonstrate  that  IL-4  increases  the  level  of 
P-selectin constitutively present on the cell surface, as well 
as the  quantity  of P-selectin  that  can be mobilized to  the 
plasma  membrane  from  Weibel-Palade  bodies.  As  mea- 
sured with the same assays, OSM also  increased P-selectin 
protein in HUVEC (data not shown). 
More  Neutrophils  Adhere  to  P-Selectin  on  IL-4-stimulated 
HUVEC  under Both  Static and Flow Conditions,  We  next 
asked whether the IL-4-induced increase in P-selectin pro- 
tein enhanced the adhesion ofneutrophils to HUVEC. We 
used neutrophils because they do not express functional or4 
integrins, except in response to certain stimuli (71).  There- 
fore, neutrophils do not interact with VCAM-1  (6, 64, 72), 
which is expressed on IL-4-activated HUVEC (20-23).  In 
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Figure  8.  Stinmlation of HUVEC with IL-4 increases  P-selectin  pro- 
tein.  HUVEC were preincubated with fresh  medium in the presence or 
absence  of 20 ng/ml IL-4 for 24 h. (A) Cells were lysed in buffer contain- 
ing Triton X-100,  and the amount of P-selectin  in the ]ysate was mea- 
sured by ELISA.  (B) Cells were fixed with 1% paraformaldehyde.  A satu- 
rating concentration (1  txg/ml) of 12si-$12, an anti-P-selectin mAb, was 
added  in the  absence or presence of 0.2%  saponin to  measure,  respec- 
tively,  surface  or total  P-selectin.  (C)  Live  cells treated with or without 
10  s M  histamine were incubated with  1 Ixg/ml '25I-$12  for 30  nfin at 
37~  to measure P-selectin cycling  between endosomes and the plasma 
membrane. For each assay, the data represent the mean +- SEM of deter- 
minations from duplicate  wells performed in each of five independent ex- 
periments. 
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Figure 9.  More neutrophils adhere to P-selectin on IL-4-stimulated 
HUVEC under both static and flow conditions.  Confluent HUVEC were 
pretreated with fresh medium in the presence or absence of 20 ng/ml of 
IL-4 for 24 h.  (A) HUVEC in 24-well dishes were washed twice with 
HBSS and then incubated at 37~  with 2 ￿  10  -5 M histamine  in HBSS/ 
HSA in the presence or absence of the blocking anti-P-selectin mAb G1. 
After the indicated  time, the buffer  was replaced with 5 ￿  105 neutrophils 
in HBSS/HSA in the presence or absence of mAb G1. After 5 min at 
37~  the nonadherent cells were removed by washing  twice with HBSS. 
The number of adherent neutrophils  was quantified  with a myeloperoxi- 
dase assay. The data represent the mean +  range of duplicate determina- 
tions, and  are  representative of three independent experiments. (B) 
HUVEC in 35-ram dishes were washed twice with HBSS and then in- 
serted into a parallel-plate  flow chamber. Neutrophils (106/1nl  in HBSS/ 
HSA) were perfused through the chamber at a wall shear stress of 1.5 
dyn/cm  2  in the presence or absence ofmAb G1. After 10 rain, 2 ￿  10  -s M 
histamine was added to the perfusate. At each time point, the number of 
attached neutrophils was measured by viewing six random 20￿  fields. 
The data represent the mean +- SD of the attached cells in each field, and 
are representative  of three independent experiments. 
static  adhesion assays,  few  neutrophils adhered to  control 
HUVEC (Fig. 9 A). As observed previously (32, 73), neu- 
trophils  adhered  transiently to  HUVEC  stimulated with 
histamine; adhesion peaked 3  min after addition of hista- 
mine and then rapidly declined to basal levels. More neutro- 
phils  adhered  to  IL-4-treated HUVEC,  even in the  ab- 
sence  of  histamine,  and  significantly  more  neutrophils 
transiently adhered after stimulation with histamine. Neu- 
trophils  did  not  attach  to  unstimulated HUVEC  under 
conditions  of hydrodynamic flow  (Fig.  9  B).  However, 
neutrophils rolled on HUVEC immediately after the mono- 
layer was  stimulated with  histamine, confirming previous 
results  (74).  Neutrophils rolled on IL-4-treated HUVEC, 
even in the  absence of histamine, and significantly more 
neutrophils rolled on HUVEC after stimulation with hista- 
mine (Fig. 9 B). Neutrophil adhesion under both static and 
flow conditions was blocked by G1, an mAb to P-selectin, 
indicating that  the  observed  adhesion was  to  P-selectin. 
These results demonstrate that  neutrophils attach  and roll 
on P-selectin that is constitutively expressed on the surface 
of IL-4-treated HUVEC. Treatment with histamine mobi- 
lizes  additional P-selectin from  Weibel-Palade bodies  to 
the cell surface, promoting attachment of even more neu- 
trophils. 
IL-4 Increases P-Selectin mRNA in Murine Endothelial Cells 
and in Human Lung Microvascular Endothelial Cells.  To  de- 
termine whether IL-4 affected P-selectin mRNA  levels in 
endothelial cells  other  than  HUVEC,  we  added  IL-4  to 
murine bEnd.3 endothelioma cells and to human lung mi- 
crovascular endothehal cells. The amounts of P-selectin or 
VCAM-1  mRNA  were  then measured by Northern blot 
analysis. We used murine IL-4 to stimulate bEnd.3 cells be- 
cause of the restricted species specificity of IL-4 for its re- 
ceptor (75). We also used a murine P-selectin cDNA probe 
(46)  to measure P-selectin mRNA in bEnd.3 cells. Consti- 
tutively expressed P-selectin mRNA  was detected in mu- 
rine bEnd.3 cells, but not in human lung microvascular en- 
dothelial cells  (Fig.  10).  IL-4 increased P-selectin mRNA 
levels in bEnd.3 cells.  The kinetics of accumulation after 
IL-4 treatment were different than those observed in HU- 
VEC;  transcripts were  detected after 4  h, peaked at  10 h, 
and persisted at this level for at least 24 h.  IL-4 increased 
P-selectin mRNA  in human lung microvascular endothe- 
lial cells; the kinetics of accumulation were similar to those 
in HUVEC,  although much less  P-selectin mRNA  accu- 
mulated  relative  to  total  R.NA.  IL-4  also  modestly  in- 
creased VCAM-1 mR.NA in the human lung microvascular 
endothelial cells.  TNF-o~  increased  P-selectin mRNA  in 
bEnd.3 cells, consistent with previous results with other mu- 
fine endothelioma cells (46). However, TNF-o~ did not in- 
crease P-selectin mRNA in human lung microvascular en- 
dothelial  cells,  although  it  markedly  increased VCAM-1 
transcripts.  These  data  demonstrate  that  IL-4  increases 
P-selectin mRNA  in murine endothehal cells and human 
lung microvascular endothelial cells as well as in HUVEC. 
In contrast, TNF-~x increases P-selectin mRNA in murine 
endothelial cells, but not in the human endothelial cells ex- 
amined. 
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and in human lung microvascular endothelial cells. Murine bend.3  en- 
dothelioma  cells and  human  lung  microvascular endothelial  cells 
(HLMEC) were treated with 100 U/rnl TNF-~ or 20 ng/ml oflL-4. Af- 
ter the indicated time, total P,.NA was isolated and analyzed  by Northern 
blotting, as described in Fig. 1. The data are representative of four inde- 
pendent experiments for bEnd.3 cells and two independent experiments 
for the HLMEC. 
Discussion 
Megakaryocytes  and  venular  endothelial  cells  constitu- 
tively synthesize P-selectin and then store it in the oL gran- 
ules of platelets  and the Weibel-Palade  bodies of endothe- 
lium  (27-30).  Histamine  and  other  secretagognes  rapidly 
mobilize  P-selectin  to  the  cell  surface,  where  it  mediates 
the initial tethering and rolling of neutrophils on the vessel 
wall  during  acute  inflammation  (32,  41,  76).  Endothelial 
cells  stimulated with secretagogues normally limit the time 
that P-selectin can function by clearing it from the surface 
by endocytosis (37, 38). However, P-selectin has also been 
observed on the luminal  surface of endothelial  cells in tis- 
sues with chronic or allergic inflammation (43-45). In these 
conditions, there must be mechanisms that prolong the sur- 
face  expression  of P-selectin.  We  found  that  IL-4  and 
OSM,  two cytokines that are elaborated during chronic or 
allergic  inflammation,  increased  P-selectin  mlLNA in  cul- 
tured  endothelial  cells  for  as  long  as  72  h.  Some  of the 
newly translated P-selectin protein reached the cell surface, 
where  it mediated  tethering  of neutrophils  under static  or 
flow  conditions.  These  data  suggest  that  IL-4  and  OSM 
provide a mechanism to signal sustained expression of  P-selec- 
tin on the endothelial cell surface during inflammation. 
In  HUVEC,  IL-4  increased  the  steady-state  level  of 
P-selectin mRNA by accelerating its transcription. Because 
P-selectin  transcripts  have a long half-life,  even a brief in- 
crease in the transcription rate could ensure a prolonged ac- 
cumulation ofP-selectin mlkNA. HUVEC pretreated with 
inhibitors  of tyrosine  kinases  did  not  increase  P-selectin 
transcripts  in response  to  IL-4 or OSM.  This  is  consistent 
with  known  signaling  mechanisms  for  these  cytokines, 
which include  rapid  tyrosine phosphorylation of  Janus  ki- 
nases  and  signal  transducer  and  activator  of transcription 
(STAT)  proteins  that  associate  with  the  cytoplasmic  do- 
mains ofligand-occupied receptors (65, 66). IL-4 and OSM 
bind to distinct receptors, and, in cells studied to date, IL-4 
causes phosphorylation of Stat6, whereas OSM causes phos- 
phorylation of Stat3 (65, 66). However, Stat3 and Stat6 can 
bind to the same regulatory element in some genes, provid- 
ing a  potential  mechanism for the  induction  of P-selectin 
expression by either  IL-4 or OSM  (66,  77).  Furthemlore, 
both  cytokines might phosphorylate  common STATs  not 
yet described,  or signal through shared mechanisms that do 
not involve Stats  (78).  Both IL-4 and OSM required  new 
protein synthesis to increase  P-selectin mP,.NA, suggesting 
that  the  cytokines  functioned  indirectly  by  activating  the 
gene(s)  for one or more other proteins that then  activated 
the P-selectin gene.  IL-4 also increased  P-selectin  mP,  NA 
in murine endothelioma cells.  In these  cells,  transcripts  ac- 
cumulated  and  then  declined  somewhat  earlier  than  in 
HUVEC.  We  have  not yet determined  whether  IL-4 re- 
quires  new protein  synthesis to increase  P-selectin mRNA 
in murine endothelial cells. 
Unlike  IL-4  or  OSM,  the  mediators  TNF-<x,  IL-1[3, 
LPS, or IL-3 had little or no effect on P-selectin mRNA in 
HUVEC.  Furthermore,  they  did not augment  the  IL-4- 
induced accumulation of P-selectin RNA.  In fact, TNF-ot 
or LPS sometimes decreased the level of P-selectin mRNA 
after  10-24  h,  as  observed  previously  (51).  Whether  this 
decline in transcripts reflects reduced synthesis or increased 
turnover  is  unknown.  The  inability  of TNF-0L  to  elevate 
P-selectin  mRNA  is  in  contrast  to  a  modest  increase  in 
P-selectin antigen reported on the surface of HUVEC treated 
with TNF-ot for 6 h, although P-selectin mR.NA levels were 
not  measured  in  that  study  (79).  It was  recently  reported 
that IL-3 induces a  1.9-fold increase  in P-selectin mRNA 
in HUVEC  (80).  This small increase  in P-selectin mRNA 
by IL-3 was occasionally observed in our experiments,  but 
it was much less than that induced by IL-4 or OSM. 
In contrast to their lack of effect on P-selectin mRNA  in 
HUVEC, TNF-o~ or LPS clearly increase P-selectin mlkNA 
in cultured murine and bovine endothelial cells (46).  In vivo, 
these mediators also increase P-selectin mRNA  and protein 
levels  in  rodent  endothelial  cells  (46,  48-50).  P-selectin 
transcripts  reach  a  maximum  2-4  h  after  stimulation  and 
then decline to basal levels within  12-24 h  (46, 48, 49). It is 
possible  that  TNF-oL,  IL-1[3,  and  LPS  increase  human 
P-selectin  mRNA  levels  in  vivo,  but  not  in  HUVEC  or 
the  human  microvascular  endothelial  cells  that  we  exam- 
ined in vitro. However, P-selectin mRNA levels decline in 
the atria of patients  after cardiopulmonary bypass, whereas 
mRNA  levels  for  E-selectin  and  ICAM-1  increase  (51). 
Furthermore,  LPS  injected  intradermally  in  rhesus  mon- 
keys results in loss of P-selectin antigen in venular endothe- 
lial  cells,  whereas  the  antigen  for E-selectin  appears  (81). 
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gene in primates in the same manner as the P-selectin gene 
in species such as mice and rats.  These mediators mobilize 
heterodimeric  NF-KB proteins from the cytoplasm to the 
nucleus, where they bind to KB elements of responsive genes 
encoding proteins such as E-selectin, ICAM-1, and VCAM-1 
(5).  The promoter of the human gene for P-selectin has a 
KB element, but it binds only homodimers of p50 or p52 
(82).  This suggests that TNF-ci, IL-l[3, and LPS either do 
not activate the human P-selectin gene, or regulate it by a 
mechanism different  than  that  used  for genes  with  more 
conventional ~B elements.  It will be informative to com- 
pare the putative regulatory elements in the promoters of 
the murine and human P-selectin genes. If there are differ- 
ences in how this gene is regulated across species, functions 
ascribed to P-selectin in some animal models of inflamma- 
tion may not apply to humans. 
HUVEC do not constitutively synthesize VCAM-1, but 
they do express VCAM-1  in response to IL-4 (20-22, 63). 
TNF-e~,  IL-lJ3,  or  LPS  also  increase  VCAM-1  mRNA, 
but with different kinetics than does IL-4 (63;  this study). 
Any of these mediators combined with IL-4 enhances and 
prolongs the accumulation of VCAM-1 transcripts (63; this 
study).  This synergy results from transcriptional activation 
of the VCAM-1  gene by TNF-ot (and probably IL-lJ3 and 
LPS)  plus prolongation  of the  otherwise  short  half-life of 
VCAM-1 mRNA by IL-4 (63).  In vivo, IL-4 may be most 
effective in inducing VCAM-1 expression when low levels 
of another mediator such as TNF-ot are also present  (63). 
In contrast, IL-4 may increase expression of P-selectin, even 
in  the  absence  of such  additional  mediators.  Like  IL-4, 
OSM increases P-selectin mRNA, but unlike IL-4, it does 
not induce VCAM-1  mRNA.  OSM might selectively in- 
crease the  expression of P-selectin in the presence of low 
levels of TNF-o~ that are insufficient to induce transcription 
of VCAM-1.  IL-4  suppresses  the  induced  expression  of 
E-selectin and ICAM-1 by TNF-ot (83).  Thus, the relative 
levels of IL-4, OSM,  and other mediators such as TNF-ot 
may  differentially  regulate  the  expression  of P-selectin, 
VCAM-1, and other adhesion molecules during chronic or 
allergic inflammation. 
IL-4 or  OSM  also  elevated P-selectin protein  in  HU- 
VEC, although not to the same degree as P-selectin mRNA. 
The relatively limited increase in protein probably reflects 
its complex subceUular trafficking. After synthesis, P-selectin 
is sorted in the trans-Golgi network for delivery to secre- 
tory granules,  where  it has a relatively long half-life (39). 
The protein  that  is  not  sorted  is  delivered  to  the  plasma 
membrane,  where  it  is  rapidly  internalized  in  clathrin- 
coated pits (37,  38).  The half-life of missorted P-selectin is 
short because it is efficiently delivered from endosomes to 
lysosomes for degradation  (39).  Although  some P-selectin 
molecules may recycle from endosomes to the trans-Golgi 
network and be resorted (40), in vivo immunohistochemi- 
cal  studies  suggest  that  this  is  a  relatively minor pathway 
(81). An increase in the level of newly synthesized P-selectin 
may saturate the sorting pathway, increasing the fraction of 
molecules  that  travel  directly  to  the  cell  surface  and  are 
then degraded. Thus, a large increase in P-selectin mRNA 
might produce a relatively hmited increase in protein. 
IL-4-treated HUVEC expressed more P-selectin on the 
plasma  membrane  as  well  as  in  Weibel-Palade  bodies, 
where  it  could be mobilized to  the  cell surface by hista- 
mine.  Under  static  conditions,  IL-4 effected only a  small 
increase in neutrophil adhesion to P-selectin in the absence 
of histamine.  Previous  studies  did  not  note  this  increase, 
perhaps because it was modest compared to the increased 
adhesion ofeosinophils, monocytes, and T  cells to VCAM-1 
on IL-4-treated HUVEC (21,  22). Under flow conditions, 
the increase in P-selectin was sufficient to mediate rolling 
of neutrophils in the absence of histamine, and even more 
neutrophils  attached  after the  addition  of histamine.  It is 
not yet known whether these densities of P-selectin medi- 
ate  attachment  of flowing  eosinophils,  monocytes,  or  T 
cells.  These  leukocytes  express  0t4  integrins  that  interact 
with VCAM-1  (64,  72,  84),  which  could stabilize attach- 
ment mediated by even low densities of P-selectin.  Other 
inducible molecules such as a ligand for L-selectin may en- 
hance tethering under flow (23).  IL-4 and OSM might also 
have important "priming" functions.  The cytokines could 
chronically increase the steady-state levels of P-selectin on 
the plasma membrane. Subsequent challenges that generate 
histamine, thrombin, or complement could mobilize an ad- 
ditional larger pool of P-selectin to the cell surface. Patho- 
logic mediators such as oxygen-derived radicals might fur- 
ther increase surface expression of P-selectin by interfering 
with endocytosis (85). 
In the multistep model of leukocyte recruitment, the se- 
quential  interactions  of different  adhesion  molecules  are 
regulated by specific signaling molecules. Different combi- 
nations  of adhesion  and  signaling  molecules  may control 
the classes of leukocytes that emigrate into sites  of inflam- 
mation, and the kinetics of their accumulation (1).  The in- 
flammatory cytokines IL-4 and OSM have many signaling 
functions (14-17, 24-26). We found that they also induce a 
sustained increase in the expression of P-selectin in endo- 
thelial cells.  This may provide a mechanism for P-selectin 
to mediate leukocyte adhesion,  not  only during  acute in- 
flammation, but also during chronic and allergic inflamma- 
tion. 
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